China Medical & HealthCare Group Limited provided unaudited consolidated guidance for the five months ended May 31, 2022. For the period, the Group is expected to record a Net Loss for the five months ended 31 May 2022 which represents an approximately 316% increase as compared with the Net Loss for the corresponding period in 2021; an approximately 40% to 50% decrease, when compared with the Net Loss for the six months, ended 30 June 2021; or an approximately 77% to 87% increase, when compared with the Net Loss for the six months, ended 30 June 2021 excluding the one-off non-recurring item of impairment loss recognized on loan receivable.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.69 HKD | -.--% | +1.47% | -13.75% |
05-20 | Tian an Medicare Limited Approves Final Dividend for the Year Ended 31 December 2023 | CI |
05-02 | China Medical & HealthCare Changes Name to Tian An Medicare | MT |
1st Jan change | Capi. | |
---|---|---|
-13.75% | 95.82M | |
-23.39% | 15.56B | |
-2.70% | 11.65B | |
+2.65% | 11.58B | |
+2.37% | 10.06B | |
+29.48% | 8.7B | |
-10.45% | 7.16B | |
+8.05% | 6.85B | |
-4.29% | 5.71B | |
-3.96% | 4.3B |
- Stock Market
- Equities
- 383 Stock
- News Tian An Medicare Limited
- China Medical & HealthCare Group Limited Provides Unaudited Consolidated Guidance for the Five Months Ended May 31, 2022